Loading clinical trials...
Loading clinical trials...
The purpose of the study is to build and assess the feasibility of a therapeutic education program, constructed in collaboration with the urologists of the University Hospital of Saint Etienne. The aim of this therapeutic education program is to delay the onset or to reduce the amplitude of the development of insulin resistance and side effects of androgen deprivation therapy in patients treated with androgen deprivation in the context of an evolutive prostate cancer.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
CHU Saint-Etienne
Saint-Etienne, France
Institut de Cancérologie de la Loire
Saint-Priest-en-Jarez, France
Start Date
April 1, 2014
Primary Completion Date
November 1, 2014
Completion Date
November 1, 2014
Last Updated
June 2, 2015
9
ACTUAL participants
therapeutic education program
BEHAVIORAL
Lead Sponsor
Institut de Cancérologie de la Loire
NCT05691465
NCT06842498
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04550494